Vanguard Health Care ETF (VHT)
173.40
+0.47 +0.27%
NYSE Arca
Aug 20, 16:59
Delayed 2m
USD
VHT Key Stats
| Net Asset Value | Upgrade |
| Discount or Premium to NAV | Upgrade |
| Turnover Ratio | Upgrade |
| 1 Year Fund Level Flows | Upgrade |
View All VHT News
VHT News
-
WireHeadlineTime (ET)
-
MT Newswires08/20 13:58
-
MT Newswires08/20 09:12
-
MT Newswires08/16 13:30
-
MT Newswires08/16 09:26
-
MT Newswires08/15 13:37
-
SA Breaking News08/15 10:32
-
MT Newswires08/15 09:16
-
MT Newswires08/14 13:35
-
MT Newswires08/14 09:18
-
MT Newswires08/13 13:31
VHT Performance
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | 3.68% | 3.71% | 0.85% | 22 |
| 3M | 9.98% | 9.94% | 7.41% | 24 |
| 6M | 8.77% | 8.73% | 8.83% | 43 |
| YTD | 12.91% | 12.90% | 14.06% | 47 |
| 1Y | 20.80% | 20.74% | 23.02% | 51 |
| 3Y | 8.29% | 8.28% | 5.62% | 23 |
| 5Y | 15.49% | 15.49% | 14.82% | 41 |
| 10Y | 13.17% | 13.17% | 13.34% | 54 |
VHT Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.33% | 0.33% | 0.00% |
| Stock | 99.66% | 99.66% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.01% | 0.01% | 0.00% |
VHT Region Exposure
| Americas | 99.95% |
| North America | 99.90% |
| Latin America | 0.05% |
| Greater Europe | 0.04% |
| United Kingdom | 0.00% |
| Europe Developed | 0.04% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 0.01% |
| Japan | 0.00% |
| Australasia | 0.00% |
| Asia Developed | 0.01% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 99.97% |
| % Emerging Markets | 0.03% |
VHT Stock Sector Exposure
| Basic Materials | 0.00% |
| Communication Services | 0.00% |
| Consumer Cyclical | 0.00% |
| Consumer Defensive | 0.00% |
| Energy | 0.00% |
| Financial Services | 0.03% |
| Healthcare | 98.42% |
| Industrials | 0.06% |
| Real Estate | 0.00% |
| Technology | 1.49% |
| Utilities | 0.00% |
VHT Stock Market Capitalization
| Giant | 47.26% |
| Large | 33.61% |
| Medium | 13.07% |
| Small | 5.46% |
| Micro | 0.60% |
VHT Stock Style Exposure
| Large Cap Value | 30.60% |
| Large Cap Blend | 26.38% |
| Large Cap Growth | 24.17% |
| Mid Cap Value | 1.52% |
| Mid Cap Blend | 2.26% |
| Mid Cap Growth | 9.34% |
| Small Cap Value | 0.55% |
| Small Cap Blend | 1.38% |
| Small Cap Growth | 3.80% |
View More Holdings
As of July 31, 2018
VHT Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 8.74% | 136.89 | +1.80% |
| UNH | UnitedHealth Group Inc | 6.03% | 262.49 | +0.06% |
| PFE | Pfizer Inc | 5.85% | 42.33 | +0.57% |
| MRK | Merck & Co Inc | 4.37% | 70.25 | +1.72% |
| ABBV | AbbVie Inc | 3.44% | 97.70 | -1.12% |
| AMGN | Amgen Inc | 3.26% | 197.54 | +0.06% |
| MDT | Medtronic PLC | 3.01% | 90.20 | -0.44% |
| ABT | Abbott Laboratories | 2.81% | 64.64 | -0.12% |
| GILD | Gilead Sciences Inc | 2.51% | 72.36 | -0.77% |
| LLY | Eli Lilly and Co | 2.40% | 105.81 | +0.25% |
Advertisement
VHT One Page Reports
- One Page Report Download
VHT Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Blend |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | Vanguard |
| Benchmark Index | |
|---|---|
MSCI US IMI/Health Care 25-50 GR USD |
100.0% |
VHT Manager Info
| Name | Tenure |
|---|---|
| Michelle Louie | 0.67 yrs |
| Walter Nejman | 2.61 yrs |
VHT Net Fund Flows
| 1M | 82.47M |
| 3M | 110.26M |
| 6M | 83.79M |
| YTD | 63.22M |
| 1Y | 121.21M |
| 3Y | 412.90M |
| 5Y | 3.769B |
| 10Y | 4.706B |
VHT Risk Info
| Beta (5Y) | 0.926 |
| Max Drawdown (All) | 39.01% |
| Historical Sharpe (10Y) | 1.062 |
| Historical Sortino (All) | 0.9472 |
| 30-Day Rolling Volatility | 8.46% |
| Daily Value at Risk (VaR) 1% (All) | 2.90% |
| Monthly Value at Risk (VaR) 1% (All) | 12.79% |
VHT Fundamentals
| Dividend Yield TTM (8-20-18) | 1.21% |
| SEC Yield (8-17-18) | 1.37% |
| Weighted Average PE Ratio | 26.81 |
| Weighted Average Price to Sales Ratio | 1.891 |
| Weighted Average Price to Book Ratio | 4.147 |
| Weighted Median ROE | 13.41% |
| Weighted Median ROA | 3.63% |
| Forecasted Dividend Yield | 1.44% |
| Forecasted PE Ratio | 16.89 |
| Forecasted Price to Sales Ratio | 1.784 |
| Forecasted Price to Book Ratio | 3.740 |
| Number of Holdings | 378 |
VHT Growth Estimates
| Forecasted 5 Yr Earnings Growth | 11.23% |
| Forecasted Book Value Growth | 6.53% |
| Forecasted Cash Flow Growth | 7.17% |
| Forecasted Earnings Growth | -1.24% |
| Forecasted Revenue Growth | 8.69% |
VHT Attributes
| Key Dates | |
|---|---|
| Inception Date | 1/26/2004 |
| Termination Date | |
| Last Annual Report Date | 8/31/2017 |
| Last Prospectus Date | 12/21/2017 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Fixed Distribution Fund | No |
| High-Net Worth Individual Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
VHT Excel Add-In Codes
- Name: =YCI("VHT","name")
- Broad Asset Class: =YCI("VHT", "broad_asset_class")
- Broad Category: =YCI("VHT", "broad_category_group")
- Prospectus Objective: =YCI("VHT", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
